EDGAR Filing Documents for 0001171843-19-002996

Form 8-K - Current report:

SEC Accession No. 0001171843-19-002996

Filing Date

2019-05-06

Accepted

2019-05-06 17:02:41

Documents

Period of Report

2019-05-06

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_050619.htm	8-K	10597
2	PRESS RELEASE	exh_991.htm	EX-99.1	58185
	Complete submission text file	0001171843-19-002996.txt		70062

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 19800140
SIC: 2834 Pharmaceutical Preparations